Health Care & Life Sciences » Healthcare Provision | Hangzhou Tigermed Consulting Co. Ltd.

Hangzhou Tigermed Consulting Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
94,747.40
136,395.30
173,891.50
156,780.70
332,173.20
506,797.20
Depreciation, Depletion & Amortization
5,034.70
12,801.50
31,714.10
36,612.60
32,550.00
61,201.80
Other Funds
1,842.90
59,783.10
66,646.20
562,236.40
680,028.10
39,321.70
Funds from Operations
106,641.30
156,570.90
218,280.70
205,136.90
402,474.00
532,700.50
Changes in Working Capital
29,092.50
107,850.60
31,555.80
8,948.10
31,530.10
8,499.40
Net Operating Cash Flow
77,548.80
48,720.30
186,724.90
214,084.90
370,943.90
541,199.90
Capital Expenditures
37,446.20
38,103.90
87,080.70
61,659.20
45,963.50
Sale of Fixed Assets & Businesses
6.60
215.60
7,956.30
13,023.00
26,049.50
Purchase/Sale of Investments
102,763.70
12,233.70
171,279.60
415,662.10
346,492.90
Net Investing Cash Flow
140,203.20
224,517.80
414,177.80
552,176.10
902,377.70
Cash Dividends Paid - Total
42,720.00
42,720.00
43,003.80
47,074.10
50,017.70
Issuance/Reduction of Debt, Net
-
225,460.70
9,538.20
53,715.10
72,330.80
Net Financing Cash Flow
40,877.10
122,957.70
14,104.10
461,447.20
702,341.20
Net Change in Cash
105,629.00
52,068.90
201,647.50
137,913.40
161,579.90
Free Cash Flow
40,102.60
10,616.40
99,644.20
152,425.80
324,980.50
Deferred Taxes & Investment Tax Credit
430.90
3,737.00
4,561.30
7,523.40
10,864.20
4,023.20
Net Assets from Acquisitions
-
198,863.20
163,773.80
87,877.80
535,970.80
Exchange Rate Effect
2,097.40
770.90
11,701.30
14,557.40
9,327.60

About Hangzhou Tigermed Consulting Co.

View Profile
Address
15th floor
Hangzhou Zhejiang 310053
China
Employees -
Website http://www.tigermed.net
Updated 07/08/2019
Hangzhou Tigermed Consulting Co., Ltd. provides clinical research services for research and development of domestic and foreign pharmaceutical and health related products. Its services include technical services for phase I to phase IV clinical trials, registration and declaration of clinical trials, on-site services, as well as data management and analysis, etc. The company was founded on December 15, 2004 and is headquartered in Hangzhou, China.